These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 35641004)
1. Primary characteristics and outcomes of newly diagnosed low-grade endometrial stromal sarcoma. Smith ES; Jansen C; Miller KM; Chiang S; Alektiar KM; Hensley ML; Mueller JJ; Abu-Rustum NR; Leitao MM Int J Gynecol Cancer; 2022 Jul; 32(7):882-890. PubMed ID: 35641004 [TBL] [Abstract][Full Text] [Related]
2. Does ovarian preservation have an effect on recurrence of early stage low-grade endometrial stromal sarcoma? Karataşlı V; Çakır İ; Can B; Erkılınç S; Karadeniz T; Kuru O; Gökçü M; Sancı M J Obstet Gynaecol; 2021 Jul; 41(5):797-802. PubMed ID: 33063586 [TBL] [Abstract][Full Text] [Related]
3. Stages I to II WHO 2003-defined low-grade endometrial stromal sarcoma: how much primary therapy is needed and how little is enough? Feng W; Hua K; Malpica A; Zhou X; Baak JP Int J Gynecol Cancer; 2013 Mar; 23(3):488-93. PubMed ID: 23435438 [TBL] [Abstract][Full Text] [Related]
4. Outcomes and relapse patterns of stage IB grade 2 or 3 endometrial cancer treated with adjuvant vaginal brachytherapy. Hochreiter A; Kelly JR; Young MR; Litkouhi B; Black JD; Stromberger C; Higgins S; Schwartz PE; Damast S Int J Gynecol Cancer; 2020 Jan; 30(1):48-55. PubMed ID: 31722964 [TBL] [Abstract][Full Text] [Related]
6. Three-Year Recurrence-Free Survival in Patients With a Very Low Risk of Endometrial Cancer Who Did Not Undergo Lymph Node Dissection (Tree Retro): A Korean Multicenter Study. Kim M; Choi C; Kim K; Lim MC; Park JY; Hong JH; Lee M; Paek J; Seoung J; Lee S; Lee TS Int J Gynecol Cancer; 2018 Jul; 28(6):1123-1129. PubMed ID: 29664841 [TBL] [Abstract][Full Text] [Related]
7. Endometrial stromal sarcoma: treatment and patterns of recurrence. Thomas MB; Keeney GL; Podratz KC; Dowdy SC Int J Gynecol Cancer; 2009 Feb; 19(2):253-6. PubMed ID: 19396004 [TBL] [Abstract][Full Text] [Related]
8. Role of lymphadenectomy for apparent early stage uterine sarcoma; a comprehensive analysis of the National Cancer Database. Nasioudis D; Mastroyannis SA; Latif NA; Ko EM; Haggerty AF; Kim SH; Morgan MA; Giuntoli RL Surg Oncol; 2021 Sep; 38():101589. PubMed ID: 33957499 [TBL] [Abstract][Full Text] [Related]
9. Exploring metastasis and recurrence patterns in low-risk grade 3 endometrial cancer: A multicenter retrospective cohort study. Aiob A; Lee KB; Kim SI; Kim NK; Kang S; Lee CH; Jeong DH; Lee B; Kim K Eur J Obstet Gynecol Reprod Biol; 2024 Oct; 301():154-159. PubMed ID: 39137594 [TBL] [Abstract][Full Text] [Related]
10. Localized high grade endometrial stromal sarcoma and localized undifferentiated uterine sarcoma: a retrospective series of the French Sarcoma Group. Meurer M; Floquet A; Ray-Coquard I; Bertucci F; Auriche M; Cordoba A; Piperno-Neumann S; Salas S; Delannes M; Chevalier T; Italiano A; Blay JY; Mancini J; Pautier P; Duffaud F Int J Gynecol Cancer; 2019 May; 29(4):691-698. PubMed ID: 30772825 [TBL] [Abstract][Full Text] [Related]
12. Lymphadenectomy in uterine low-grade endometrial stromal sarcoma: an analysis of 19 cases and a literature review. Signorelli M; Fruscio R; Dell'Anna T; Buda A; Giuliani D; Ceppi L; Milani R Int J Gynecol Cancer; 2010 Nov; 20(8):1363-6. PubMed ID: 21051978 [TBL] [Abstract][Full Text] [Related]
13. Clinical study investigating the role of lymphadenectomy, surgical castration and adjuvant hormonal treatment in endometrial stromal sarcoma. Amant F; De Knijf A; Van Calster B; Leunen K; Neven P; Berteloot P; Vergote I; Van Huffel S; Moerman P Br J Cancer; 2007 Nov; 97(9):1194-9. PubMed ID: 17895898 [TBL] [Abstract][Full Text] [Related]
14. Survival and recurrence in stage II endometrial cancers in relation to uterine risk stratification after introduction of lymph node resection and omission of postoperative radiotherapy: a Danish Gynecological Cancer Group Study. Ørtoft G; Høgdall C; Hansen ES; Dueholm M J Gynecol Oncol; 2020 Mar; 31(2):e22. PubMed ID: 31912677 [TBL] [Abstract][Full Text] [Related]
15. A Multicentre Retrospective Review of Clinical Characteristics of Uterine Sarcoma. Wais M; Tepperman E; Bernardini MQ; Gien LT; Jimenez W; Murji A J Obstet Gynaecol Can; 2017 Aug; 39(8):652-658. PubMed ID: 28729098 [TBL] [Abstract][Full Text] [Related]
16. Is lymph node dissection mandatory among early stage endometrial cancer patients? A retrospective study. Zhang G; Chen H; Liu Y; Niu L; Jin L; Li D; Song L; Shang L; Lin X; Wang F; Li F; Zhang X; Zhang X; Gao Y; Qiu D; Zhang Y; Na R; Su R BMC Womens Health; 2020 Nov; 20(1):258. PubMed ID: 33213444 [TBL] [Abstract][Full Text] [Related]
17. Outcomes for patients with high-risk endometrial cancer undergoing sentinel lymph node assessment versus full lymphadenectomy. Holtzman S; Stoffels G; Flint M; Carr C; Prasad-Hayes M; Zeligs K; Blank SV Gynecol Oncol; 2023 Jul; 174():273-277. PubMed ID: 37270906 [TBL] [Abstract][Full Text] [Related]
18. Surgery and adjuvant radiation therapy of endometrial stromal sarcoma. Weitmann HD; Kucera H; Knocke TH; Pötter R Wien Klin Wochenschr; 2002 Jan; 114(1-2):44-9. PubMed ID: 12407935 [TBL] [Abstract][Full Text] [Related]
19. Low-grade and high-grade endometrial stromal sarcoma: A National Cancer Database study. Seagle BL; Shilpi A; Buchanan S; Goodman C; Shahabi S Gynecol Oncol; 2017 Aug; 146(2):254-262. PubMed ID: 28596015 [TBL] [Abstract][Full Text] [Related]
20. Vaginal brachytherapy alone for patients with Stage II endometrial cancer with inner half cervical stromal invasion. Barnes EA; Parra-Herran C; Martell K; Barbera L; Taggar A; Leung E Brachytherapy; 2019; 18(5):606-611. PubMed ID: 31200993 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]